Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Lignans, derived from flaxseed, are phyto-oestrogens being increasingly studied for their health benefits. An 8-week, randomised, double-blind, placebo-controlled study was conducted in fifty-five hypercholesterolaemic subjects, using treatments of 0 (placebo), 300 or 600 mg/d of dietary secoisolariciresinol diglucoside (SDG) from flaxseed extract to determine the effect on plasma lipids and fasting glucose levels. Significant treatment effects were achieved (P < 0·05 to < 0·001) for the decrease of total cholesterol (TC), LDL-cholesterol (LDL-C) and glucose concentrations, as well as their percentage decrease from baseline. At weeks 6 and 8 in the 600 mg SDG group, the decreases of TC and LDL-C concentrations were in the range from 22·0 to 24·38 % respectively (all P < 0·005 compared with placebo). For the 300 mg SDG group, only significant differences from baseline were observed for decreases of TC and LDL-C. A substantial effect on lowering concentrations of fasting plasma glucose was also noted in the 600 mg SDG group at weeks 6 and 8, especially in the subjects with baseline glucose concentrations ≥ 5·83 mmol/l (lowered 25·56 and 24·96 %;P = 0·015 and P = 0·012 compared with placebo, respectively). Plasma concentrations of secoisolariciresinol (SECO), enterodiol (ED) and enterolactone were all significantly raised in the groups supplemented with flaxseed lignan. The observed cholesterol-lowering values were correlated with the concentrations of plasma SECO and ED (r 0·128–0·302;P < 0·05 to < 0·001). In conclusion, dietary flaxseed lignan extract decreased plasma cholesterol and glucose concentrations in a dose-dependent manner.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vanharanta, M., Voutilainen, S., Lakka, T. A., van der Lee, M., Adlercreutz, H., & Salonen, J. T. (1999) · The Lancet · doi:10.1016/s0140-6736(99)05031-x · Cited by 246
Dodin, S., Lemay, A., Jacques, H., Légaré, F., Forest, J.-C., & Mâsse, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1148 · Cited by 244
Hypocholesterolemic and antiatherosclerotic effect of flax lignan complex isolated from flaxseed
Prasad, K. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.11.012 · Cited by 232 · cited 3×
“Stuglin and Prasad(24) recently reported that a 4-week intake of 32·7 g flaxseed did not substantially alter plasma TC concentration in fifteen healthy men by a self-controlled trial.”
Background
Research works printed but not linked: 43
- 10.1210/jcem.87.4.8374 · DOI · Paper page
- 10.1093/ajcn/65.5.1645S · DOI · Paper page
- Cunnane, 2003, Flaxseed in Human Nutrition, 63
- 10.1097/00001721-200312000-00003 · DOI
- 10.1093/jn/134.5.1197 · DOI
- 10.1016/S0021-9150(97)00239-6 · DOI · Paper page
- 10.1079/BJN2002601 · doi:10.1079/bjn2002601
- Juntunen, 2000, Consumption of wholemeal rye bread increases serum concentrations and urinary excretion of enterolactone compared with consumption of white wheat bread in healthy Finnish men and women, Br J Nutr, 84, 839, 10.1017/S0007114500002452 · DOI · Paper page
- 10.1016/S0090-4295(01)01014-7 · DOI · Paper page
- Du, 2006, Determination of secoisolariciresonol diglucoside, secoisolariciresonol, enterolactone and enterodiol in serum by LC/MS/MS, J Chin Mass Spectrom Soc, 27, 168
- 10.1007/s11745-003-1185-7 · DOI
- Hutchins, 2003, Flaxseed in Human Nutrition, 127
- 10.1053/j.ajkd.2005.08.031 · DOI
- 10.1093/jn/134.10.2691 · DOI
- 10.1079/BJN19930046 · DOI · Paper page
- 10.1016/S0021-9150(97)06110-8 · DOI · Paper page
- 10.1016/j.atherosclerosis.2003.12.032 · DOI
- 6 Westcott N , Muir A & Northrup S (1998) Analysis of flaxseed lignan after enzymatic and chemical extraction. In Proceedings of the 57th Flax Institute of the United States, pp. 27–30. Fargo, ND: Flax Institute of the United States..
- 10.1016/S0301-2115(98)00281-4 · DOI · Paper page
- 10.1016/j.metabol.2005.02.010 · DOI
- Vaisey-Genser, 2003, Flax, 1
- Mazur, 2000, Phyto-oestrogen content of berries, and plasma concentrations and urinary excretion of enterolactone after a single strawberry-meal in human subjects, Br J Nutr, 83, 381
- 10.1161/01.CIR.99.10.1355 · DOI · Paper page
- 10.1093/ajcn/73.6.1094 · DOI · Paper page
- 10.1093/ajcn/61.1.62 · DOI · Paper page
- Pietinen, 2001, Serum enterolactone and risk of breast cancer: a case-control study in eastern Finland, Cancer Epidemiol Biomarkers Prev, 10, 339
- 10.1093/ajcn/69.3.549 · DOI · Paper page
- 10.1016/j.urology.2003.12.010 · DOI
- 10.1111/j.1753-4887.2004.tb00002.x · DOI · Paper page
- 10.1016/S0944-7113(97)80063-3 · DOI
- Stavro, 2003, Flaxseed in Human Nutrition, 288
- 10.1016/S0021-9673(03)01136-1 · DOI · Paper page
- 10.1080/07315724.2003.10719289 · DOI
- Duan, 2003, Flaxseed in Human Nutrition, 1
- 10.1194/jlr.M400448-JLR200 · DOI
- 10.1093/jn/131.10.3168 · DOI · Paper page
- 10.1177/107424840501000103 · DOI
- 10.1093/jn/136.1.112 · DOI
- 10.1080/07315724.2003.10719336 · DOI
- 10.1016/S0005-2760(97)00040-4 · DOI
- 10.1161/01.ATV.17.6.1163 · DOI · Paper page
- 10.1677/joe.0.1420251 · DOI · Paper page
- Lemay, 2002, Flaxseed dietary supplement versus hormone replacement therapy in hypercholesterolemic menopausal women, Obstet Gynecol, 100, 495
Cited by
Peterson, J., Dwyer, J., Adlercreutz, H., Scalbert, A., Jacques, P., & McCullough, M. L. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00319.x · Cited by 376
Flaxseed (Linum usitatissimum L.) bioactive compounds and peptide nomenclature: A review
Shim, Y. Y., Gui, B., Arnison, P. G., Wang, Y., & Reaney, M. J. T. (2014) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2014.03.011 · Cited by 319
Health Effects with Consumption of the Flax Lignan Secoisolariciresinol Diglucoside
Adolphe, J. L., Whiting, S. J., Juurlink, B. H. J., Thorpe, L. U., & Alcorn, J. (2010) · British Journal of Nutrition · doi:10.1017/s0007114509992753 · Cited by 314
“The study used an SDG-rich flaxseed extract consisting of 33 % SDG, in contrast to defatted flaxseed meal which has an SDG concentration between 0·97 and 3·09 % (w/w) (9) .”
InfluentialMeta-analysis of the effects of flaxseed interventions on blood lipids
Pan, A., Yu, D., Demark-Wahnefried, W., Franco, O. H., & Lin, X. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27469 · Cited by 264
The cardiovascular effects of flaxseed and its omega-3 fatty acid, alpha-linolenic acid
Rodriguez-Leyva, D., Bassett, C. M. C., McCullough, R., & Pierce, G. N. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)70455-4 · Cited by 262
Metadata
- Authors
- Zhang, W., Wang, X., Liu, Y., Tian, H., Flickinger, B., Empie, M. W., & Sun, S. Z.
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2008-06
- Volume
- 99
- Issue
- 6
- Pages
- 1301-1309
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W2126548793
- Cited by
- 214
- References
- 3
- FWCI
- 4.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. https://app.cochat.ai/papers/10.1017/s0007114507871649
- The paper
- Zhang, W., Wang, X., Liu, Y., Tian, H., Flickinger, B., Empie, M. W., & Sun, S. Z. (2008). Dietary flaxseed lignan extract lowers plasma cholesterol and glucose concentrations in hypercholesterolaemic subjects. British Journal of Nutrition. https://doi.org/10.1017/s0007114507871649
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.